>>> US Ckose Dow -0.36% S&P +0.00% Nasdaq +0.21% Russell -0.91%

Closing Stock Market Summary
The stock market had a somewhat lackluster session after last week's volatile price action.

The S&P 500 closed less than one point above its prior closing level while the Dow Jones Industrial Average (-0.4%) and Nasdaq Composite (+0.2%) closed slightly lower and slightly higher than Friday's settlement.

The muted action was due to hesitation in front of market-moving economic releases. The Producer Price Index (Tuesday), the Consumer Price Index (Wednesday), Retail Sales (Thursday), and Housing Starts (Friday) are among the influential reports.

Only three of the S&P 500 sectors settled higher while the real estate (-0.6%) and communication services (-0.6%) sectors logged the biggest declines. The information technology sector led the pack, rising 0.9%, followed by energy (+0.5%) and utilities (+0.2%).
The info tech sector was boosted by gains in Apple (AAPL 217.53, +1.54, +0.7%),
Microsoft (MSFT 406.81, +0.79, +0.2%), NVIDIA (NVDA 109.02, +4.27, +4.1%), and Broadcom (AVGO 148.62, +0.36, +0.2%).

The energy sector reacted to a jump in oil prices ($79.91/bbl, +3.13, +4.1%) on geopolitical angst after the recent death of Hamas political leader Ismail Haniyeh stirred concerns about a retaliation from Iran (and/or its proxies) against Israel.

Separately, the New York Fed's Survey of Consumer Expectations showed that median one- and five-year-ahead inflation expectations were unchanged in July at 3.0% and 2.8%, respectively, while median three-year-ahead inflation expectations declined by 0.6 percentage point to 2.3%. This was the lowest level since the survey's started in June 2013.

The 10-yr note yield settled three basis points lower at 3.91% and the 2-yr note yield fell three basis points to 4.02%.
  • S&P 500: +12.1% YTD
  • Nasdaq Composite:+11.8% YTD
  • S&P Midcap 400: +4.8% YTD
  • Dow Jones Industrial Average: +4.4% YTD
  • Russell 2000: +1.7% YTD

Reviewing today's economic data:
  • The Treasury Budget for July showed a deficit of $243.7 billion compared to a deficit of $220.8 billion in the same period a year ago. The July deficit resulted from outlays ($574.1 billion) exceeding receipts ($330.4 billion). The Treasury Budget data is not seasonally adjusted so the July deficit cannot be compared to the June deficit, which was revised higher to $70.9 billion (from -$66.0 billion).
    • The key takeaway from the report is that the U.S. government continues to run large budget deficits, driven in part by net interest costs that are outweighing defense spending.

Tuesday's economic lineup features:
  • 6:00 ET: July NFIB Small Business Optimism (prior 91.5)
  • 8:30 ET: July PPI (consensus 0.1%; prior 0.2%) and Core PPI (consensus 0.2%; prior 0.4%)

>>> Insider Trading: notable purchases -- CEO adds to ZI; notable sales -- Tria

Insider Trading: notable purchases -- CEO adds to ZI; notable sales -- Trian Fund active in WEN
Buyers:
  • ACA President and Chief Executive Officer bought 12,125 shares at $80.32 - $82.75 worth approx. $995K.
  • AGCO Director bought 1,415 shares at $88.26 - $88.31 worth about $125K.
  • APLE Executive Chairman bought 5,000 shares at $14.045 worth about $70K.
  • APPN 10% owner Abdiel Capital bought 275,000 shares worth approx. $7.6 mln.
  • AXR 10% owner bought 5,000 shares at $23.125 - $23.68 worth about $117K.
  • CTOS President - Sales bought 84,254 shares at $3.95 - $4.00 worth approx. $335K.
  • DIS Director bought 11,756 shares at $85.0191 - $85.09 worth approx. $1 mln.
  • GRPN Director bought 15,000 shares at $10.61 worth about $159K.
  • GT President, EMEA bought 18,292 shares at $8.20 worth about $150K.
  • LAB 10% owner Casdin Partners bought 1,069,562 shares worth approx. $1719K.
  • LGND Chief Executive Officer bought 2,500 shares at $97.3922 worth approx. $243K.
  • ML Director bought 10,000 shares at $42.62 - $47.62 worth approx. $459K.
  • ODP Director bought 3,875 shares at $25.77 worth ~$100K.
  • ONEW Directors (2) bought 61,705 shares worth approx. $1.4 mln.
  • PBF 10% owner Control Empresarial de Capitales S.A. de C.V. bought 73,000 shares worth nearly $2.7 mln.
  • PMTS Director bought 2,000 shares at $25.26 worth ~$51K.
  • PRAA Director bought 11,750 shares at $21.25 - $21.45 worth approx. $251K.
  • SHEN President / Chief Executive Officer bought 18,500 shares at $14.84 - $14.96 worth approx. $276K.
  • TALO 10% owner Control Empresarial de Capitales S.A. de C.V. bought 650,000 shares at $10.275 - $10.40 worth approx. $6.7 mln.
  • TBPH 10% owner bought 999,800 shares worth approx. $7.8 mln.
  • WLKP SVP, Olefin Material & Corp Pr bought 12,000 shares at $22.89 - $23.00 worth ~$276K.
  • XRAY Director bought 8,212 shares at $24.305 - $24.38 worth about $200K.
  • ZI Chief Executive Officer bought 1,500,000 shares at $8.17 - $8.70 worth approx. $12.7 mln.
Sellers:
  • ATGE Director sold 67,330 shares at $71.24 - $71.88 worth approx. $4.8 mln.
  • QDEL 10% owner Carlyle Group (CG) sold 184,885 shares worth approx. $7.5 mln.
  • MUSA Director sold 13,454 shares at $514.38 worth approx. $6.9 mln.
  • PEBK Director sold 8,686 shares at $28.906 worth approx. $251K.
  • PGY Chief Revenue Officer and Chief Technology Officer sold 23,263 shares combined at $15.60 - $16.25 worth about $368K.
  • PIPR General Counsel sold 1,789 shares at $256.73 worth approx. $459K.
  • SFM Director sold 20851 shares at $96.0407 - $96.2826 worth more than $2.0 mln.
  • SIRI President & Chief Content Officer sold 1,447,238 shares at $3.125 to $3.20worth approx. $4.6 mln.
  • SNCR 10% owner B. Riley Financial (RILY) sold 98,564 shares worth approx. $1.1 mln.
  • VYX Chief Executive Officer and Executive VP & CFO bought 20,000 shares combined at $11.02 - $11.51 worth approx. $226K.
  • WCN Senior VP Operations sold 1,000 shares at $180.15 worth about $180K.
  • WEN 10% owner Trian Fund sold 1,000,000 shares worth approx. $17.2 mln.

TechCrunch : Synopsys’s plans to buy Ansys for $35B falls on UK regulatory radar

Synopsys’s plans to buy Ansys for $35B falls on UK regulatory radar


Startups
Venture
Apple
Security
AI
Apps
Events
Startup Battlefield
More
Government & Policy
Synopsys’s plans to buy Ansys for $35B falls on UK regulatory radar
Paul Sawers
5:45 AM PDT • August 12, 2024
Comment

Close-up of sign with logo at Silicon Valley headquarters of technology company Synopsys, Mountain View, California.
Image Credits: Smith Collection/Gado/Getty Images
The U.K. antitrust regulator has confirmed that it’s carrying out an early-stage inquiry into Synopsys‘s plans to buy Ansys.

The Competition and Markets Authority (CMA) has opened an “invitation to comment,” meaning any stakeholders or interested parties can file their objections to the transaction, after which the regulator will decide whether to progress the investigation to a formal merger inquiry. The CMA hasn’t provided any deadline for comment submissions.

Chip design software maker Synopsys revealed back in January its plans to acquire Ansys, a simulation software developer that helps engineers model and analyze the physical behavior of products (e.g. chips) to evaluate their real-world performance, in a deal worth $35 billion.

The coming together of these companies would create a comprehensive chip design and simulation powerhouse, one that’s capable of creating more efficient development processes by lowering the fail-rate during the design process. However, such a merger could create a dominant player spanning all facets of the chip design process, thus stifling competitors that don’t offer such a combination.

The Federal Trade Commission (FTC) is already looking at the transaction, though has yet to confirm any further action, and reports suggest that competitors and customers of Synopsys and Ansys are pressuring the European Commission (EC) to take action.

China’s SAMR is also expected to scrutinize the deal — Synopsys has longstanding ties to China, where it has seen significant success even with Huawei sanctions in place, and Ansys too has a notable presence in China.

With the CMA now weighing in, it seems that Synopsys and Ansys — both publicly-traded companies with a combined market cap of $100 billion — might have a long way to go before this deal reaches the finish line.

WSJ : Universal Music Pens Meta Deal Allowing Its Music to Appear on WhatsApp

Universal Music Pens Meta Deal Allowing Its Music to Appear on WhatsApp
Companies say monetization opportunities for Universal Music artists and songwriters have been expanded with short-form video and licensed music for WhatsApp

Universal Music Group artists will see their songs made available on WhatsApp for the first time, after the record label struck a new licensing deal with Meta Platforms.

The world’s largest music company has signed an expanded multi-year global agreement that allows music from its artists and songwriters to be used and shared across Meta’s global network of platforms, including Facebook, Instagram, Messenger, Horizon, Threads and WhatsApp. The group’s artists include Taylor Swift, Adele and Elton John.

The two companies initially penned a deal in 2017 that saw Universal Music license its recorded music and music publishing catalogs across Facebook’s platforms, which mainly covered songs used in the background of videos and “other social experiences” on Facebook, Messenger, Instagram and Oculus.

That deal paved the way for a new revenue stream for the industry, as user-generated videos hadn’t before generated income for artists and relied on burdensome legal proceedings to have unlicensed content removed.

With Monday’s new agreement, the companies said monetization opportunities for Universal Music artists and songwriters have been expanded with short-form video and licensed music for WhatsApp.

“The new agreement reflects the two companies’ shared commitment to protecting human creators and artistry, including ensuring that artists and songwriters are compensated fairly,” the companies said in a joint statement.

They will also continue to work together to address the growing threat from unlicensed AI-generated content that could affect artists and songwriters, they said.

The deal follows an agreement earlier this year with TikTok that saw Universal Music Group artists and their songs return to the popular video-sharing app after months of disagreements over pay.

Meta has similar licensing agreements with publishers such as Warner Music Group and independent music licensing agency Merlin.

FT : US sends submarine to Middle East as fears grow of reprisal against Israel

US sends submarine to Middle East as fears grow of reprisal against Israel
Aircraft carrier also heads to region as Washington assesses threat of strike on its ally by Iran or proxy forces

The US is sending a guided missile submarine to the Middle East, as it bolsters its regional presence amid fears Iran and its proxies are poised to retaliate against Israel for the killing of senior Hamas and Hizbollah figures.

US defence secretary Lloyd Austin has also ordered the USS Abraham Lincoln aircraft carrier, which is equipped with F-35 fighter jets, to “accelerate its transit to the region” in light of the “escalating tensions”.

“Secretary Austin reiterated the United States’ commitment to take every possible step to defend Israel,” the Pentagon said in a statement on Sunday, which it issued after Austin had spoken to his Israeli counterpart Yoav Gallant.

Gallant’s office said on Monday that he and Austin had discussed the “interoperability” of Israeli and US forces in the region. He warned on Sunday that “whoever harms us in a way that has not been done in the past, is likely to be hit in a way that hasn’t been done in the past”.

“I hope that they will think this through and won’t get to a point where they will force us to cause significant damage and increase the chances of war breaking out on additional fronts. We do not want this, but we must be prepared,” he said.

Iran has been vowing to “punish” Israel since Hamas’s political leader Ismail Haniyeh was assassinated in Tehran last month, hours after he attended the inauguration of Iran’s new president, Masoud Pezeshkian.

Meanwhile, Hizbollah, has pledged to retaliate against Israel for its killing a day earlier of Fuad Shukr — one of the Lebanese militant group’s most senior commanders — in response to a suspected Hizbollah missile strike that killed 12 youngsters on a football pitch in the occupied Golan Heights.

While Israel has acknowledged that it was behind Shukr’s killing, it has neither confirmed nor denied that it killed Haniyeh, in line with its long-standing policy of not commenting on operations in Iran.

But both Iran and Hamas have blamed Israel for Haniyeh’s assassination, which has fuelled fears that the region could be sliding towards an all-out war, and left diplomats from the US and other countries working frantically to de-escalate the situation.

The leaders of France, Germany and the UK called on Iran and its allies “to refrain from attacks that would further escalate regional tensions”.

“No country or nation stands to gain from a further escalation in the Middle East,” the leaders said in a joint statement on Monday.

The statement, signed by French President Emmanuel Macron, German Chancellor Olaf Scholz and British Prime Minister Keir Starmer, called for an immediate ceasefire in the 10-month war between Israel and Hamas, and for the Palestinian militant group to release the hostages it still holds in the wake of its October 7 attack on Israel that triggered the hostilities.

US President Joe Biden and the leaders of Qatar and Egypt last week said mediators were making an urgent push to resume stalled hostage talks on Thursday in the hope of securing a ceasefire and preventing a further escalation.

>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:
  • RILY -23.2%, HE -11.2%, SSL -2.2%, CLSK -1.5%, RNA -1.3%
Other news:
  • SCPH -12.2% (FDA approval of supplemental new drug application expanding the FUROSCIX indication in heart failure; announces topline study results for SCP-111; proposed underwritten public offering of common stock and pre-funded warrants)
  • FTRE -9.2% (misses by $0.10, misses on revs; guides FY24 revs below consensus)
  • HUMA -8% (Announces FDA Communication of Additional Time Required to Complete Review of acellular tissue engineered vessel (ATEV) BLA for the Treatment of Vascular Trauma)
  • JBLU -5.8% ($400 million convertible senior notes offering; proposes senior secured loyalty notes offering and senior secured loyalty term loan)
  • SKLZ -3.6% (to delay 10-Q filing)
  • GPMT -3.4% (files $500 mln mixed shelf securities offering)
  • MARA -3.2% (proposes offering of $250 mln of convertible senior notes due 2031)
  • MGTX -2.7% (offering of 12,500,000 of its ordinary shares at an offering price of $4.00 per share)
  • LTH -2.4% (offering of 12,000,000 shares of common stock)
  • SHIM -2.1% (to delay 10-Q filing)
  • AMTX -1.6% (files for $234 mln mixed securities shelf offering)
  • CP -1.2% (to issue TCRC lockout notice for Aug. 22)
  • RIOT -1.2% (files mixed securities shelf offering; entered into $750 mln Controlled Equity Offering Sales Agreement)

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:
  • SKYE +19%, MNDY +8.3%, NIU +5.5%, BORR +5% (revs guidance), BEKE +4.1%, APGE +3.7%, CDRE +3.4%, GOLD +2.4%
Other news:
  • KEY +15.3% (receives strategic minority investment from Scotiabank)
  • ASND +6.5% (FDA Approves YORVIPATH (Palopegteriparatide) as the First and Only Treatment for Hypoparathyroidism in Adults)
  • TBRG +4.9% (files to delay 10-Q; has determined that it will prepare and file amendments to the 2023 Form 10-K and the Q1 2024 Form 10-Q in order to disclose the material weakness in internal controls)
  • ZI +3.3% (CEO bought 1,500,000 shares at $8.17 - $8.70 worth approx. $12.7 mln)
  • LTRX +3.3% (enters cooperation agreement with 180 Degree Capital Corp)
  • SBUX +2.5% (report that activist investor Starboard Value has a stake, according to WSJ)
  • AIOT +2.3% (to delay 10-Q filing)
  • SMLR +2.1% (files $150 mln mixed shelf securities offering)
  • WRN +1.9% (provides Yukon Environmental update)
  • RKLB +1.7% (successfully completes latest launch with Capella Space)
  • CGNT +1.5% (sends letter to shareholders, urging shareholders to reject Value Base Fund's director nominee)
  • SNDX +1% (Publication in the Journal of Clinical Oncology of Data from the Pivotal AUGMENT-101 Trial of Revumenib)

>>> US Research Calls

Research Calls
  • Upgrades:
    • Allstate (ALL) upgraded to Equal Weight from Underweight at Wells Fargo; tgt raised to $177
    • Blend Labs (BLND) upgraded to Buy from Hold at Canaccord Genuity; tgt raised to $4.75
    • Brown & Brown (BRO) upgraded to Overweight from Equal Weight at Wells Fargo; tgt raised to $112
    • Churchill Downs (CHDN) upgraded to Buy from Neutral at BofA Securities; tgt raised to $155
    • Diageo plc (DEO) upgraded to Sector Perform from Underperform at RBC Capital Mkts
    • Goldman Sachs BDC (GSBD) upgraded to Equal Weight from Underweight at Wells Fargo; tgt lowered to $12
    • Liberty Global (LBTYA) upgraded to Neutral from Underperform at BofA Securities; tgt raised to $21.30
    • Robinhood Markets (HOOD) upgraded to Overweight from Neutral at Piper Sandler; tgt raised to $23
  • Downgrades:
    • Algonquin Power & Utilities (AQN) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $6
    • Bank of Hawaii (BOH) downgraded to Underweight from Neutral at Piper Sandler; tgt lowered to $61
    • Brighthouse Financial (BHF) downgraded to Underweight from Equal Weight at Wells Fargo; tgt lowered to $40
    • Hillenbrand (HI) downgraded to Neutral from Buy at DA Davidson; tgt lowered to $33
    • Janus International Group (JBI) downgraded to Peer Perform from Outperform at Wolfe Research
  • Others:
    • Arcturus Therapeutics (ARCT) initiated with an Outperform at Leerink Partners; tgt $70
    • Ardent Health Partners (ARDT) initiated with a Buy at Truist; tgt $21
    • Ardent Health Partners (ARDT) initiated with an Outperform at Leerink Partners; tgt $23
    • Ardent Health Partners (ARDT) initiated with an Outperform at Mizuho; tgt $20
    • Ardent Health Partners (ARDT) initiated with a Neutral at JP Morgan; tgt $18
    • Ardent Health Partners (ARDT) initiated with an Overweight at Morgan Stanley; tgt $27
    • Ardent Health Partners (ARDT) initiated with an Outperform at RBC Capital Mkts; tgt $23
    • Conagra (CAG) initiated with a Buy at Goldman; tgt $36
    • Hershey Foods (HSY) initiated with a Sell at Goldman; tgt $185
    • J. Jill (JILL) initiated with a Hold at TD Cowen; tgt $37
    • Kellanova (K) initiated with a Neutral at Goldman; tgt $75
    • Kraft Heinz (KHC) initiated with a Sell at Goldman; tgt $34
    • LENZ Therapeutics (LENZ) initiated with a Buy at H.C. Wainwright; tgt $38

>>> US Research Calls II

Research Calls II
  • Upgrades:
    • Camden Property (CPT) upgraded to Buy from Underperform at BofA Securities; tgt raised to $147
    • Eli Lilly (LLY) upgraded to Buy from Hold at Deutsche Bank; tgt $1025
    • Mid-America Aptmt (MAA) upgraded to Buy from Underperform at BofA Securities; tgt raised to $189
    • PAR Technology (PAR) upgraded to Buy from Hold at Jefferies; tgt raised to $60
    • Prudential (PRU) upgraded to Equal Weight from Underweight at Wells Fargo; tgt $113
    • Take-Two (TTWO) upgraded to Buy from Hold at HSBC Securities; tgt $179
    • Zentalis Pharma (ZNTL) upgraded to Neutral from Underperform at Wedbush; tgt $4
  • Downgrades:
    • EchoStar (SATS) downgraded to Underweight from Neutral at JP Morgan; tgt $12
    • Lion Electric (LEV) downgraded to Neutral from Buy at DA Davidson; tgt lowered to $1
    • Pacira BioSciences (PCRX) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt lowered to $14
    • Pacira BioSciences (PCRX) downgraded to Mkt Perform from Outperform at Raymond James
    • Pacira BioSciences (PCRX) downgraded to Underweight from Overweight at JP Morgan; tgt lowered to $10
    • Pacira BioSciences (PCRX) downgraded to Neutral from Overweight at Piper Sandler; tgt lowered to $11
    • Piedmont Lithium (PLL) downgraded to Neutral from Outperform at Macquarie; tgt $9.30
    • Pilgrim's Pride (PPC) downgraded to Market Perform from Outperform at BMO Capital Markets; tgt $46
    • Prologis (PLD) downgraded to Neutral from Buy at BofA Securities; tgt $128
    • Qualcomm (QCOM) downgraded to Peer Perform from Outperform at Wolfe Research
    • Sylvamo (SLVM) downgraded to Neutral from Buy at BofA Securities; tgt raised to $82
    • Triumph Group (TGI) downgraded to Hold from Buy at Jefferies; tgt lowered to $14
  • Others:
    • Ardent Health Partners (ARDT) initiated with a Buy at Citigroup; tgt $21
    • Ardent Health Partners (ARDT) initiated with an Overweight at Stephens; tgt $24
    • Ardent Health Partners (ARDT) initiated with a Buy at Loop Capital; tgt $18
    • Dave, Inc. (DAVE) initiated with a Buy at The Benchmark Company; tgt $53
    • General Mills (GIS) initiated with a Buy at Goldman; tgt $76
    • GE Vernova (GEV) initiated with a Buy at HSBC Securities; tgt $215
    • Mondelez Int'l (MDLZ) initiated with a Buy at Goldman; tgt $80
    • Morningstar (MORN) initiated with an Outperform at BMO Capital Markets; tgt $352
    • Tempus AI (TEM) initiated with a Neutral at Piper Sandler; tgt $40
    • TWFG, Inc. (TWFG) initiated with a Mkt Perform at Keefe Bruyette; tgt $27
    • TWFG, Inc. (TWFG) initiated with a Buy at UBS; tgt $29
    • TWFG, Inc. (TWFG) initiated with an Outperform at RBC Capital Mkts; tgt $29
    • TWFG, Inc. (TWFG) initiated with an Overweight at JP Morgan; tgt $26.50
    • TWFG, Inc. (TWFG) initiated with an Overweight at Piper Sandler; tgt $27
    • TWFG, Inc. (TWFG) initiated with an Equal-Weight at Morgan Stanley; tgt $23
    • TWFG, Inc. (TWFG) initiated with an Outperform at BMO Capital Markets; tgt $30
    • Walmart (WMT) added to Positive Tactical Trading Call at Evercore ISI